These findings are important in demonstrating that methylation of the HOXA11 gene might be a good prognostic molecular marker in patients with gastric adenocarcinoma, especially because this disease is a cause of almost 800,000 yearly deaths worldwide [2]. This evidence concerns the gene HOXA11 and gastric adenocarcinoma.